First cases and risk factors of super yeast Candida auris infection or colonization from Shenyang, China

Emerging Microbes & Infections
Sufei TianHong Shang

Abstract

For the first time, we identified 15 cases of Candida auris in Shenyang, China, and then performed a risk factor assessment for these patients compared with 30 control subjects who were hospitalized in the same ward during the same period of time as the infected patients. We found that diarrhea, gastrointestinal decompression, infection, or colonization with other Candida isolates (especially Candida albicans) and tetracycline antibiotics were all risk factors for C. auris infection or colonization. Diarrhea and tetracycline antibiotics were independent risk factors. We suggest clinicians pay special attention to the emergence of multidrug-resistant C. auris infections or colonization.

References

Jul 1, 2011·Journal of Clinical Microbiology·Wee Gyo LeeHee-Chang Jang
Sep 21, 2013·Emerging Infectious Diseases·Anuradha ChowdharyJacques F Meis
Oct 15, 2013·Journal of Gastroenterology and Hepatology·Lawrence R SchillerJoseph H Sellin
Jun 26, 2014·Emerging Infectious Diseases·Rindidzani E MagoboNelesh P Govender
May 20, 2015·Emerging Infectious Diseases·Maha EmaraRitu Bafna
Oct 9, 2015·The New England Journal of Medicine·Bart Jan Kullberg, Maiken C Arendrup
Jul 28, 2016·The Journal of Infection·Belinda CalvoArnaldo Lopes Colombo
Oct 26, 2016·Antimicrobial Resistance and Infection Control·Silke SchelenzMatthew C Fisher
Dec 19, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shawn R LockhartAnastasia P Litvintseva
Dec 29, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S VallabhaneniT M Chiller
Jan 19, 2017·Emerging Infectious Diseases·Ronen Ben-AmiTalya Finn
Jun 6, 2017·The Journal of Infection·Turkiya Al-SiyabiBadriya Al'Adawi
Aug 5, 2017·The Lancet Infectious Diseases·David S PerlinAna Alastruey-Izquierdo
Feb 17, 2018·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Adnan AlatoomImran Mirza

❮ Previous
Next ❯

Citations

Feb 19, 2019·Mycoses·Shabir A Lone, Aijaz Ahmad
Sep 5, 2019·Frontiers in Microbiology·Milena Kordalewska, David S Perlin
May 3, 2019·Current Infectious Disease Reports·Graham M Snyder, Sharon B Wright
May 1, 2020·Frontiers in Genetics·Aleksandra D ChybowskaRhys A Farrer
Oct 23, 2020·PLoS Pathogens·Han DuGuanghua Huang
Feb 19, 2021·Journal of Medical Microbiology·Arunaloke Chakrabarti, Prashant Sood
Aug 7, 2021·Pathogens·Zsófia TischnerDonát Magyar
Sep 10, 2020·ACS Infectious Diseases·Shuru FanHan Du
Nov 2, 2021·Frontiers in Cellular and Infection Microbiology·Dingchen LiLi Han

❮ Previous
Next ❯

Datasets Mentioned

BETA
KC692039
MH124607

Software Mentioned

SPSS
BioEdit

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
David Sears, Brian S Schwartz
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Effrossyni Gkrania-Klotsas, Ronald C Hershow
Revista chilena de infectología : órgano oficial de la Sociedad Chilena de Infectología
Cecilia Tapia, Christian Batarce
Journal of Infection and Public Health
Baha AbdalhamidAli Omrani
© 2021 Meta ULC. All rights reserved